KYN-5356

N/A

Report date: 2025/09/25 20:00:07
NMEFirst In Class

Base Information

Drug NameKYN-5356
Drug Alias NameKYN-5356MT-5356
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionkynurenine aminotransferase 2 inhibitors
Targetskynurenine aminotransferase 2
Therapy Area/IndicationsSchizophreniaCognitive DysfunctionCognition Disorders +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesKynexis BV
Inactive CompaniesN/A
Active IndicationsSchizophreniaCognitive DysfunctionCognition Disorders +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A